Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Diana Cervantes-Madrid
Repotrectinib (TPX-0005), Effectively Reduces Growth of ALK Driven Neuroblastoma Cells
Scientific Reports
Multidisciplinary
DNA Alterations in Cd133+ and Cd133- Tumour Cells Enriched From Intra-Operative Human Colon Tumour Biopsies
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
NeuroD1 Promotes Neuroblastoma Cell Growth by Inducing the Expression of ALK
Cancer Science
Cancer Research
Medicine
Oncology
ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells
Journal of Experimental Neuroscience
Neuroscience
The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Flotillin-1 Regulates Oncogenic Signaling in Neuroblastoma Cells by Regulating ALK Membrane Association
Cancer Research
Cancer Research
Oncology
ALK in Neuroblastoma: Biological and Therapeutic Implications
Cancers
Cancer Research
Oncology
Aberrant Activation of ALK Kinase by a Novel Truncated Form ALK Protein in Neuroblastoma
Oncogene
Cancer Research
Genetics
Molecular Biology
P565 Validation of Novel Growth-Promoting and Growth-Suppressing Genes in Neuroblastoma Cells
